Biorelevant dissolution testing
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Presentation
- By: DRESSMAN, Jennifer (Goethe University, Frankfurt am Main, Germany)
In the late 1990s, biorelevant dissolution testing emerged as a new tool for predicting in vivo behaviour of oral dosage forms. Test conditions were established which simulate the main features of upper gastrointestinal (GI) physiology under either fasted or fed state conditions. By testing the dissolution profile of the API under these.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.